๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study

โœ Scribed by Roux, C.; Hofbauer, L.C.; Ho, P.R.; Wark, J.D.; Zillikens, M.C.; Fahrleitner-Pammer, A.; Hawkins, F.; Micaelo, M.; Minisola, S.; Papaioannou, N.; Stone, M.; Ferreira, I.; Siddhanti, S.; Wagman, R.B.; Brown, J.P.


Book ID
123369429
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
540 KB
Volume
58
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES